0 avis
Zidovudine-β-Lactam Pronucleoside Strategy for Selective Delivery into Gram-Negative Bacteria Triggered by β-Lactamases
Archive ouverte
Edité par CCSD ; American Chemical Society -
International audience. Addressing antibacterial resistance is a major concern of the modern world. The development of new approaches to meet this deadly threat is a critical priority. In this article, we investigate a new approach to negate bacterial resistance: exploit the βlactam bond cleavage by β-lactamases to selectively trigger antibacterial prodrugs into the bacterial periplasm. Indeed, multidrugresistant Gram-negative pathogens commonly produce several β-lactamases able to inactivate βlactam antibiotics, our most reliable and widely used therapeutic option. The chemical structure of those prodrugs is based on a monobactam promoiety, covalently attached to the active antibacterial substance, the zidovudine (AZT). We describe the synthesis of 10 prodrug analogs (5a-h) in 4-9 steps and their biological activity. Selective enzymatic activation by a panel of β-lactamases is demonstrated and subsequent structure-activity relationships (SARs) are discussed. The best compounds are further evaluated for their activity on both laboratory strains and clinical isolates, preliminary stability, and toxicity.
Consulter en ligne
Suggestions
Du même auteur
